Related Experiment Video
Updated: Jan 11, 2026
Real-time Visualization and Analysis of Chondrocyte Injury Due to Mechanical Loading in Fully Intact Murine Cartilage Explants
Published on: January 7, 2019
Retinoic Acid-Loaded Cartilage Organoids Attenuate Chondrocyte Senescence in Osteoarthritis
Liang Xi1, Yongfeng Chen1, Zhuojing Luo1
1Department of Orthopaedics, Xijing Hospital, Fourth Military Medical University, Xi'an, People's Republic of China.
Background:
Osteoarthritis (OA) is a debilitating degenerative joint disease characterized by chondrocyte senescence and cartilage degradation. Despite extensive research, effective therapeutic strategies targeting the underlying mechanisms of chondrocyte senescence remain limited.
Methods:
We employed an integrated multi-omics approach combining weighted gene co-expression network analysis (WGCNA) and machine learning algorithms with the SenMayo gene set to identify key senescence-associated genes in OA. Single-cell RNA sequencing was used to characterize distinct chondrocyte subpopulations. Computational screening, molecular docking, and dynamics simulations identified potential therapeutic compounds. We engineered a triphasic gelatin methacryloyl/hyaluronic acid methacryloyl (GelMA/HAMA) cartilage organoid system for controlled delivery of retinoic acid (RA) and evaluated its efficacy in vitro and in a rat destabilization of the medial meniscus (DMM) model of OA.
Results:
Our bioinformatic analysis identified ANGPT1, MMP1, EGF, and IGF1 as critical senescence-associated genes in OA, forming the basis for a robust clinical prediction model (area under the curve [AUC] = 0.931). Single-cell analysis revealed dysregulated TGF-β1 signaling as central to senescence-mediated cartilage degeneration. In vitro, RA attenuated chondrocyte senescence by activating the TGFβ/Smad pathway, reducing apoptotic markers, and restoring extracellular matrix components. The biomimetic cartilage organoid system facilitated spatiotemporally controlled release of RA within the joint environment. When implanted in the rat OA model, these RA-loaded organoids significantly reduced cartilage degeneration as evidenced by improved Osteoarthritis Research Society International (OARSI) scores, enhanced tissue architecture, and increased cartilage thickness.
Conclusion:
Our findings establish RA delivered via biomimetic cartilage organoids as a promising therapeutic strategy that addresses the cellular mechanisms underlying OA progression. This approach may represent a paradigm shift from symptom management to disease modification by targeting chondrocyte senescence and promoting cartilage regeneration, offering new avenues for developing effective treatments for OA.
Insights
Retinoic acid (RA) delivered via biomimetic cartilage organoids effectively targets chondrocyte senescence in osteoarthritis (OA). This novel approach shows promise for disease modification and cartilage regeneration in OA treatment.
Area of Science:
- Biomedical Engineering
- Molecular Biology
- Computational Biology
Background:
- Osteoarthritis (OA) is a degenerative joint disease marked by chondrocyte senescence and cartilage breakdown.
- Current treatments for OA lack strategies targeting the root causes of chondrocyte senescence.
Purpose of the Study:
- Identify key senescence-associated genes in OA using multi-omics and machine learning.
- Develop a novel drug delivery system for OA treatment targeting chondrocyte senescence.
Main Methods:
- Integrated multi-omics (WGCNA, machine learning) and SenMayo gene set analysis.
- Single-cell RNA sequencing to analyze chondrocyte subpopulations.
- Engineered a triphasic GelMA/HAMA cartilage organoid for controlled retinoic acid (RA) delivery.
Main Results:
- Identified ANGPT1, MMP1, EGF, and IGF1 as critical OA senescence genes, forming a predictive model (AUC=0.931).
- Revealed dysregulated TGF-β1 signaling in senescence-driven cartilage degeneration.
- Demonstrated RA's efficacy in attenuating senescence and restoring ECM in vitro and in vivo (rat DMM model).
Conclusions:
- Retinoic acid (RA) delivered via biomimetic cartilage organoids is a promising OA therapeutic strategy.
- This approach targets cellular mechanisms of OA, shifting towards disease modification and cartilage regeneration.
- Offers new therapeutic avenues for osteoarthritis by addressing chondrocyte senescence.
